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Abstract
Chronic stress produces sustained elevation of corticosteroid levels, which is why it is considered one of the most potent
negative regulators of adult hippocampal neurogenesis (AHN). Several mood disorders are accompanied by elevated
glucocorticoid levels and have been linked to alterations in AHN, such as major depression (MD). Nevertheless, the
mechanism by which acute stress affects the maturation of neural precursors in the dentate gyrus is poorly understood. We
analyzed the survival and differentiation of 1 to 8 week-old cells in the dentate gyrus of female C57/BL6 mice following
exposure to an acute stressor (the Porsolt or forced swimming test). Furthermore, we evaluated the effects of the
glucocorticoid receptor (GR) antagonist mifepristone on the cell death induced by the Porsolt test. Forced swimming
induced selective apoptotic cell death in 1 week-old cells, an effect that was abolished by pretreatment with mifepristone.
Independent of its antagonism of GR, mifepristone also induced an increase in the percentage of 1 week-old cells that were
AMPA+. We propose that the induction of AMPA receptor expression in immature cells may mediate the neuroprotective
effects of mifepristone, in line with the proposed antidepressant effects of AMPA receptor potentiators.
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Introduction
Adult neurogenesis takes place in the brain of numerous
vertebrates [1], including humans [2]. Under normal physiological
conditions, this production of new neurons occurs in two brain
regions: the subventricular zone of the lateral ventricles, and the
subgranular zone (SGZ) of the dentate gyrus (DG) in the
hippocampus. Growing evidence indicates that adult hippocampal
neurogenesis (AHN) is crucial for learning and memory [3] [4].
Furthermore, alterations in AHN have been implicated in several
mood disorders [5], and many antidepressants require AHN to
exert their behavioral effects [6]. Numerous external stimuli have
been shown to modulate AHN, including physical activity [7],
environmental enrichment [8] and stress [9].
At the molecular level, the rate of AHN is regulated by a large
variety of signaling molecules, including: growth factors such as brain-
derived neurotrophic factor (BDNF) [10], insulin-like growth factor I
(IGF-I) [11] [12] [13] and vascular endothelial growth factor (VEGF)
[14]; neurotransmitters such as glutamate [15] [16]; and pro-
inflammatory cytokines [17]. Among the strongest modulators of the
rate of AHN are the adrenal corticosteroids. Stress activates the
hypothalamic-pituitary-adrenal (HPA) axis, resulting in an increase
in the levels of circulating glucocorticoids (GCs). In general terms,
high GC levels are considered negative regulators of AHN [18] [19]
[10], although the complex regulation of AHN by GCs remains
poorly understood, with many conflicting reports in the literature [20]
[21]. The physiological response to acute stress and the accompa-
nying increase in GC levels appear to be adaptative in nature, and
these events are critical for hippocampal long-term potentiation
(LTP) [22] and memory consolidation [23]. However, long-term
exposure to elevated GC levels triggers a series of alterations that may
provoke neurodegeneration in sensitive brain areas [24] [25]. In
conjunction with genetic risk factors, the inability to return to the
basal state following long- term exposure to high GC levels, known as
allostatic load [26], is considered by some authors to be a critical factor
in the development of neurodegenerative diseases such as Alzheimers
disease (AD) [27] [28] [29], and of mood disorders like MD [30] [31].
The hippocampus is highly sensitive to the effects of both GC and
stress, and it expresses high levels of corticosteroid receptors of both
high (mineralocorticoid receptors, MR) and low (glucocorticoid
receptors, GR) affinity [32] [33]. Chronic exposure to stress induces
permanent synaptic and dendritic alterations [34] [35], increases
hippocampal glutamate levels [36] [37] and decreases AHN [9].
Thus, understanding the molecular mechanisms that regulate
responses to stress, whether chronic or acute (as studied here) is
particularly important to identify therapeutic targets that modulate
these responses and that avoid the damage caused by prolonged
exposure to stress.
In recent years, GR antagonists have been proposed for the
treatment of diverse mood disorders. One such compound with a
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high degree of clinic relevance is mifepristone (RU-486), which has
been shown to normalize some of the hippocampal alterations
provoked by chronic stress [38] [39]. However, the mode of action
of this drug remains a matter of much debate and indeed, it has
been proposed that its neuroprotective effects may even be
independent of its action as a GR antagonist [40].
In the present study, we evaluated the effects of an acute stress,
the forced swim or Porsolt test, on the survival of hippocampal
newborn neurons of different ages in order to identify populations
particularly sensitive to acute stress. In addition, we evaluated the
effects of the GR antagonist mifepristone on the alterations in
hippocampal neurons induced by stress. Given the growing
interest in potentiators of AMPA-mediated glutamatergic signaling
in the treatment of depression (also known as ampakines) [41] [42]
[43], we investigated the relationship between GR blockage and
AMPA receptor expression in different populations of hippocam-
pal newborn neurons.
Materials and Methods
Animals
Ninety five female C57/BL6J mice (8 weeks of age, Harlan
Laboratories) were housed at 2261uC on a 12/12 h light/dark
cycle, with ad libitum access to food and water. Mice were kept
under standard laboratory conditions in accordance with Euro-
pean Community Guidelines (directive 86/609/EEC). Moreover,
all the animals were handled in strict accordance with good animal
practice as defined by the national animal welfare bodies (at the
Cajal Institute and CSIC, the Spanish Higher Research Council),
and all the animal work was approved by the appropriate
committees (Bioethics Committee of the Cajal Institute and CSIC,
approval certificate number BFU2007-60195, issued June 7,
2007).
Experimental design and injection of thymidine
analogues
One week after their arrival, the mice were distributed into five
groups (A–E) as summarized in Figure 1. Newborn hippocampal
neurons of 1, 2, 3, 4, 6, 7 and 8 weeks of age were labeled with
different thymidine analogues (see Figure 1). The animals in
groups A–C were used to evaluate the effect of the Porsolt test on
survival, differentiation and marker expression in hippocampal
cells of 1 to 8 weeks of age. Table 1 summarizes the injection
regimes used for 5-Chloro-29-deoxy-Uridine (CldU, 57.65 mg/Kg
i.p., Sigma-Aldrich, St. Louis, US) and 5-Iodo-29-deoxy-Uridine
(IdU, 42.75 mg/Kg i.p., Sigma-Aldrich). These doses were based
on equimolar doses of 50 mg/Kg BrdU [8]. To avoid any spurious
effects of the estrous cycle, each animal received one CldU or IdU
injection over 4 successive days, as described previously [44]. After
the periods of time indicated, half of the animals from each group
were subjected to the forced swim test [45], and they were then
sacrificed 4 or 24 hours later and compared with the control
animals. The effect of the GR antagonist mifepristone was assessed
on cell populations of different ages in both control animals and
those subjected to the forced swim test (Group D). Hence, animals
in group E were used to determine the effect of mifepristone on the
expression of different genes in both control animals and those
subjected to the forced swim test.
Porsolt test and Mifepristone administration
Animals were placed in cylindrical containers filled with water
(12 cm diameter and 29 cm tall, 23uC) for 6 minutes each day on
two consecutive days. The behavior of the animals was scored as
described previously [46]. The animals in groups D and E received
a single injection of the vehicle alone (sesame oil, Sigma-Aldrich)
or of mifepristone (i.p., 20 mg/Kg, Sigma-Aldrich) diluted in the
vehicle 30 minutes before each swim-test session. The control
animals were moved to the behavioral testing rooms along with
swim test animals, where they remained in their cages for the
duration of the tests.
Sacrifice
Mice were completely anaesthetized with pentobarbital 24
(groups A, B, C and D) or 4 hours (group E) after the last swim-test
session and they were then perfused with saline followed by 4%
paraformaldehyde in phosphate buffer (PB). The brains of the
mice were removed and post-fixed overnight in the same fixative
(groups A, B, C and D), while the animals in group E were
perfused with saline alone. The hippocampus from each of the
animals in group E was dissected out on ice and frozen at 280uC.
Histology
Coronal sections (50 mm thick) from one hemisphere were
obtained on a Leica VT1000S vibratome and series of sections
were generated comprised of every 8th section. Double or triple
immunohistochemistry was performed as described previously
[47], incubating the sections with the following primary antibodies
for 24 to 48 hours: rat anti-CldU (1:400, Accurate Chemicals,
New York, USA); mouse anti-IdU (1:500, BD Biosciences, New
Jersey, USA); rabbit anti-phospho-histone 3 (pH3,1:500, Upstate-
Cell Signaling, Boston, MA, USA); goat anti-doublecortin (DCX,
1:500, Santa Cruz, CA, USA); rabbit anti-fractin (1:500, BD
Biosciences); rabbit anti-AMPA receptor (AMPAR, 1:2000,
Abcam, Cambridge, UK), rabbit anti-GR H-300 (1:1000, Santa
Cruz); and goat anti-MR (1:400, Abcam). The binding of these
antibodies was then detected over 24 at hours at 4uC with the
following donkey Alexa-conjugated secondary antibodies as
appropriate (1:1000, Molecular Probes, Eugene, OR, US): Anti-
rabbit alexa 594-conjugated or anti-rabbit Alexa 555-conjugated
(pH3, fractin and GR detection); or anti-rat alexa 488-conjugated
(CldU detection). To visualize DCX and MR in triple immuno-
histochemistry experiments, antibody binding was detected with a
biotin-conjugated horse anti-goat antibody (1:1000 Vector Labo-
ratories Burlingame, CA, USA), followed by incubation with a
Alexa 633-conjugated Strepatividin. All the sections were
counterstained for 10 minutes with DAPI (1:1000, Calbiochem-
EMD Darmstadt, Germany).
Cell Counting
The total number of cells labeled for pH3, fractin, CldU and
IdU were counted under an optical fluorescence microscope (Leica
DMI 6000 B, oil immersion 40x objective), using the optical-
dissector method. Briefly, series composed of every 8th section
were used to analyze each of these markers, the cells labeled for
each marker in every section were counted, and the total number
of cells counted was then multiplied by 8 in order to obtain the
total number of cells [48].
The total number of immature (DCX+) and mature granule
neurons was calculated using the physical-dissector method
adapted for confocal microscopy (Leica TCS SP5) [47]. DG
volume was stereologically estimated by applying the Cavalieri
method to one series in conjunction with Nissl staining. To
investigate their phenotypes, 50 IdU or CldU positive cells per
animal were examined (1, 2, 3, 4, 6 and 7 weeks old cells) and co-
localization with either fractin, GR, MR, DCX or AMPAR was
analyzed in confocal images using the Leica Application Suite
Colocalization tool (Leica TCS SP5, oil immersion 63x objective,
Zoom factor: 3). Due to the small number of cells in 8 week-old
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cells, the percentage co-localization was not calculated at this age.
In the case of 6 and 7 week-old cells, two series have been analyzed
for each marker. The distance between the cell nuclei and the
Hilus layer was measured in confocal images immunolabeled for
both IdU (or CldU) and AMPA, and counterstained with DAPI. A
line was traced through the subgranular layer at the point where
hilus begins, and the distance between this line and the nucleus
was measured. 100 cells per animal were analyzed in this case.
Quantitative real-time Polymerase chain reaction (qPCR)
Total RNA was isolated from the Hippocampal tissues in one
hemisphere of each animal from Group E using the Illustra
RNAspin Mini kit (GE Healthcare, Uppsala, Sweden) and 1 mg
was reverse transcribed (RT) using the High capacity cDNA
Reverse Transcription kit (Applied Biosystems, Carlsbad, Califor-
nia, US). Subsequently, qPCR was performed on a 7500 Sequence
detection system thermal cycler (Applied Biosystems), analyzing
the data with the aid of the 7500 System SDS Software (Applied
Biosystems) using the Pfaffl method [49]. TaqMan gene expression
assays (Applied Biosystems) were used to study the expression of
Interleukin-6 (IL-6, Mm99999064_m1), Tumor Necrosis Factor
(TNF, Mm00443259_g1), vesicular Glutamate Transporter 1
(Mm00812886_m1), Glutamic Acid Decarboxylase 65 (Mm
00484623_m1), Brain Derived Neurotrophic factor (BDNF, Mm
00432069_m1), Insulin-like Growth factor 1 (IGF-I, Mm00
439560_m1), Glucocorticoid receptor (GR, Mm00433832_
m1) and the Mineralocorticoid receptor (MR, Mm01241597_
m1). Mouse GAPDH (Primer limited, Part Number 4352339E)
was used as an endogenous control.
Statistical Analysis
Data from experiments A, B and C were analyzed by two-way
ANOVA, with ‘‘age’’ and the ‘‘Porsolt test’’ as independent
variables. When significant interactions were detected, we
conducted a one-way ANOVA followed by a post hoc Tukey
test to identify categories significantly affected by ‘‘age’’ or ‘‘Porsolt
test’’. For experiments D and E, the data were analyzed by two-
way ANOVA to compare the four experimental groups (Control
vehicle; Control mifepristone; Porsolt vehicle and Porsolt mifep-
ristone). SPSS 17.0.1 software (SPSS, 1989; Apache Software
Foundation) was used for all the statistical analyses.
Results
Exposure to the Porsolt swim-test induces the selective
death of 1 week-old cells
When the number of newborn cells was analyzed, a significant
effect of ‘‘age’’ (F6,126 = 22.650, p,0.001) but not of the ‘‘Porsolt
test’’ (F1,126 = 2.822, p = 0.096) was evident when a two-Way
ANOVA analysis was performed, and there was also a significant
interaction with this factor (F6,126 = 2.772, p = 0.015). Indeed, post
hoc analysis revealed that exposure to the Porsolt test significantly
reduced the number of 1 week-old cells (p = 0.001, Figure 1 B),
although there was no significant effect on cell number in 2, 3, 4,
6, 7 or 8 week-old cells (p.0.1 for all). Accordingly, in animals
from groups A and B, exposure to the Porsolt test failed to alter the
total number of apoptotic fractin+ cells (F1,26 = 0.303, p = 0.587:
Figure 1 L). Representative images of the total number of IdU+ or
CldU+ cells in the different age groups (Figure 1 C–J) and of
fractin staining (Figure 1 M–R) are shown. Dual immunohisto-
chemistry against CldU and IdU, revealed no co-localization in 2
and 4 week-old cells (Figure 1 S–U).
Mifepristone selectively prevents Porsolt test-induced
apoptosis in 1 week-old hippocampal neurons
Mifepristone prevented the reduction in the number of 1 week-
old cells provoked by the Porsolt test (Mifepristone F1,27 = 0.579,
p = 0.454; Porsolt F1,27 = 2.616, p = 0.119; Interaction F3,27 =
10.490, p = 0.003; Figure 2 A), as also evident in the representative
images of the number of 1 week-old cells in each experimental
group (Figure 2 B–I). The percentage of IdU-labeled cells that also
expressed fractin+ at the moment of the sacrifice was also
Table 1. Injection dates and doses of IdU and CldU (mg/Kg) administered to animals in each experimental group.
CldU IdU
Date (Days) Dosage (mg/Kg) Date (Days) Dosage (mg/Kg)
GROUP A 214, 213, 212, 211 57.65 228, 227, 226, 225 42.75
GROUP B 221, 220, 219, 218 57.65 27, 26, 25, 24 42.75
GROUP C 256, 255, 254, 253 57.65 242, 241, 240, 239 42.75
GROUP D 249, 248, 247, 236 57.65 27, 26, 25, 24 42.75
GROUP E - - - -
Group E animals received no injections and they were used to determine the hippocampal mRNA expression. Note that the doses were based on equimolar doses of
50 mg/kg BrdU. To avoid ethe ffects of the estrous cycle, animals received one injection of CldU or IdU on 4 successive days.
doi:10.1371/journal.pone.0028376.t001
Figure 1. Experimental design and the effects of the Porsolt test on cell survival in different age cells. A Timing of thymidine analogue
injection, CldU and IdU. 1 to 8 weeks old adult newborn cells were labeled in the different experimental groups. The effect of the glucocorticoid
receptor anatgonist mifepristone was evaluated in control animals and those subjected to the Porsolt test. B The Porsolt test significantly reduced
the survival of 1 week-old IdU+ cells (p,0.001), but not those in any other age group. Data are presented as total number of IdU+/CldU+ cells 6
standard error of the mean (SE). C–J Immunohistochemistry against IdU or CldU (red) in cells counterstained with DAPI (blue) under different
experimental conditions and from different age groups. L Total number of apoptotic fractin+ cells. Forced swimming did not modify the total number
of fractin+ cells (p = 0.628). M–R Representative images of fractin staining. M–O A double labeled IdU+ (blue)/Fractin+ (red) cells. P–R Low
magnification fractin (red) staining of cells counterstained with DAPI (green). S–U Representative images of double immunohistochemistry for CldU
(green) and IdU (red) showing no co-localization in 2 and 4 week-old cells. ML: Molecular layer; GCL: Granule cell layer; SGZ: Subgranular zone; H:
Hilus. Scale bar = 100 mm.
doi:10.1371/journal.pone.0028376.g001
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measured. Exposure to the Porsolt test increased the percentage of
fractin+ 1 week-old cells, an effect that was attenuated by
mifepristone treatment (Mifepristone F1,28 = 11.301, p = 0.002;
Porsolt F1,28 = 6.174, p = 0.02; Interaction F3,28 = 6.174,
p = 0.020; Figure 2 J). However, neither the Porsolt test nor
mifepristone modified the total number of DCX+ cells (Mifepris-
tone F1,28 = 1.236, p = 0.277; Porsolt F1,28 = 0.070, p = 0.793;
Interaction F1,28 = 0.197, p = 0.661) (Figure S1 A), pH3
+ cells
(Mifepristone F1,27 = 0.002, p = 0.967; Porsolt F1,27 = 0.098,
p = 0.757; Interaction F1,27 = 0.017, p = 0.899) (Figure S1 B),
mature granule cells (Mifepristone F1,29 = 0.003, p = 0.717; Porsolt
F1,29 = 0.378, p = 0.544; Interaction F1,29 = 0.468, p = 0.444)
(Figure S1 C), or the volume of the DG (Mifepristone
F1,27 = 0.003, p = 0.090; Porsolt F1,27 = 0.378, p = 0.337; Interac-
tion F1,27 = 0.468, p = 0.459) (Figure S1 D). Likewise, neither the
Porsolt test or mifepristone affected the total number of 7 week-old
CldU+ cells (Mifepristone F1,28 = 0.073, p = 0.789; Porsolt
F1,28 = 0.052, p = 0.821; Interaction F1,28 = 0.202, p = 0.657)
(Figure S1 E), and as expected, acute mifepristone treatment
had no effect on the immobility time in the Porsolt test
(F1,23 = 0.742, p = 0.398) (Figure S1 F).
The effects of the Porsolt test and mifepristone
administration on GR and MR levels
GR expression was evaluated in immature neurons of different
ages by dual immunohistochemistry (Figure 3 B–M). Two-way
ANOVA revealed an increase in the percentage of GR+ cells as
cell age increased (F5,89 = 93.226, p,0.001), while the Porsolt test
had no effect on the proportion of GR+ cells at any of the ages
studied (F1,86 = 1.586, p = 0.212; no significant interaction,
F5,8 = 0.845, p = 0.522; Figure 3 A). Accordingly, hippocampal
GR mRNA expression was unaffected by either the Porsolt test or
mifepristone treatment (Mifepristone F1,17 = 2.011, p = 0.178;
Porsolt F1,17 = 2.924, p = 0.109; Interaction F1,17 = 0.000,
p = 0.997; Figure 3 O). The percentage of 1 week-old GR+ cells
also remained unaffected by either the Porsolt test or mifepristone
treatment (Mifepristone F1,29 = 0.273, p = 0.606; Porsolt
F1,29 = 0.068, p = 0.796; Interaction F1,29 = 0.916, p = 0.347).
MR expression was also evaluated in cells of different ages and
like GR, the percentage of MR+ cells increased with age
(F5,82 = 11.532, p,0.001) but was not affected by the Porsolt test
at any of the ages studied (F1,82 = 0.383, p = 0.538; Interaction
F5,82 = 0.371, p = 0.867. Similarly there were no changes in
Figure 2. Effects of mifepristone and the Porsolt test on the survival of 1 week-old cells. A Mifepristone prevented the decrease in the
number of 1 week-old IdU+ cells induced by exposure to the Porsolt test (interaction p = 0.005). B-I Immunohistochemistry against IdU (red) in cells
counterstained with DAPI (blue). Representative images of 1 week-old cells from each of the four experimental groups (B–E), and magnifications (F–
I). Mifepristone blocked the decrease in cell survival provoked by the Porsolt test (E, I) but it had no effect on control, unstressed animals (D, H). J
Exposure to the Porsolt test increased the percentage of 1 week-old IdU+ cells that were also fractin+ (p = 0.02), an effect that was blocked by
mifepristone treatment (interaction p = 0.02). ML: Molecular layer; GCL: Granule cell layer; SGZ: Subgranular zone; H: Hilus. Scale bar = 100 mm.
doi:10.1371/journal.pone.0028376.g002
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hippocampal MR mRNA expression in response to either the
Porsolt test or mifepristone treatment (Mifepristone F1,19 = 0.516,
p = 0.483; Porsolt F1,19 = 0.105, p = 0.749; Interaction F1,19 =
3.447, p = 0.082). Furthermore, the proportion of 1 week-old MR+
cells was not altered by either the Porsolt test or mifepristone
treatment (Mifepristone F1,27 = 1.218, p = 0.385; Porsolt F1,27 =
0.345, p = 0.642; Interaction F1,27 = 0.123, p = 0.536). The relative
mRNA expression of these and other genes are shown in Table 2.
The effects of the Porsolt test and mifepristone
administration on inflammation, glutamatergic and
gabaergic transmission, and on the expression of trophic
factors in the hippocampus
The mRNA expression of hippocampal pro-inflammatory
cytokines (IL-6 and TNF), and of the presynaptic markers of
glutamaergic (vGLUT1) and GABAergic (GAD65) neurotrans-
mission was measured by qPCR in Group E animals. Neither
exposure to the Porsolt test nor mifepristone administration
modified the expression of IL-6 (Mifepristone F1,18 = 1.156, p =
0.299; Porsolt F1,18 = 0.049, p = 0.828; Interaction F1,18 = 1.302,
p = 0.272), TNF (Mifepristone F1,15 = 0.049, p = 0.828; Porsolt
F1,15 = 2.818, p = 0.119; Interaction F1,15 = 0.737, p = 0.408),
vGLUT1 (Mifepristone F1,18 = 0.585, p = 0.456; Porsolt F1,18 =
1.209, p = 0.289; Interaction F1,18 = 0.738, p = 0.404) or GAD65
mRNA (Mifepristone F1,18 = 1.830, p = 0.196; Porsolt F1,18 =
0.001, p = 0.979; Interaction F1,18 = 0.826, p = 0.378).
The hippocampal mRNA expression of BDNF and IGF-I was
also evaluated by qPCR in Group E animals and again, neither
the Porsolt test nor mifepristone administration significantly
modified BDNF (Mifepristone F1,19 = 0.101, p = 0.755; Porsolt
F1,19 = 3.892, p = 0.066; Interaction F1,19 = 1.205, p = 0.289) or of
IGF-I mRNA expression (Mifepristone F1,19 = 0.330, p = 0.575;
Porsolt F1,19 = 0.677, p = 0.426; Interaction F1,19 = 1.205, p =
0.289).
The effects of the Porsolt test and mifepristone
administration on the maturation and differentiation of
newborn cells
The distance from the nucleus of each newborn cell to the hilus
layer was measured in at different ages and under distinct
experimental conditions. Two-way ANOVA revealed a significant
influence on this distance of ‘‘age’’ (F5,88 = 34.212, p,0.001) and
Figure 3. Glucocorticoid receptor (GR) expression. A Percentage of GR+ cells. The percentage of GR+ cells increased with age (p,0.001).
Exposure to the Porsolt test did not alter the percentage of GR+ cells in any of the age groups studied (p = 0.212). B–M Representative images of
double immunohistochemistry against IdU or CldU (red) and GR (green). Most 1 week-old cells were GR- (yellow triangles), whereas almost all 7 week-
old cells were GR+ (purple triangles). N Percentage of 1 week-old IdU+ cells that were also GR+, and neither mifepristone (p = 0.606) nor the Porsolt
test (p = 0.796) altered this percentage. O Hippocampal GR mRNA expression. Neither mifepristone (p = 0.178) nor the Porsolt test (p = 0.109) altered
GR mRNA expressionin the hippocampus when measured 4 hours after testing. GCL: Granule cell layer; SGZ: Subgranular zone; H: Hilus. Scale bar:
30 mm.
doi:10.1371/journal.pone.0028376.g003
Mifepristone Increases AMPAR in Newborn Neurons
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e28376
of the ‘‘Porsolt test’’ (F1,25 = 11.655, p,0.001), as well as a
significant interaction (F5,25 = 20.220, p = 0.014). The distance to
the hilus border increased with age (as shown in Figure 4 A) and a
post hoc analysis revealed that exposure to the Porsolt test
significantly reduced the distance to hilus in 4 (p = 0.001) and 6
(p = 0.002) week-old cells (Figure 4 A). These changes were
evident in images of cells taken from representative locations in 1
and 6 week-old cells from the different experimental groups
(Figure 4 B–E).
DCX expression in neurons from 1, 2, 3 and 4 week old cells
was evaluated in control animals and those subjected to the Porsolt
test (Figure 4 F, G–R). Two-way ANOVA revealed a significant
effect of ‘‘age’’ (F3,58 = 39.598, p,0.001) and of the ‘‘Porsolt test’’
(F1,58 = 6.966, p = 0.011) on the percentage of newborn cells
expressing DCX, as well as a significant interaction (F3,57 = 2.547,
p = 0.067). Indeed, a post hoc analysis revealed an increase in the
percentage of DCX+ cells in 4 week-old cells following exposure to
the Porsolt test when compared to the controls (p = 0.022).
Interestingly, the percentage of AMPA+ cells increased with age
(Age F6,98 = 69.256, p,0.001; Porsolt F1,98 = 3.884, p = 0.152;
Interaction F6,98 = 0.269, p = 0.929: Figure 5 A–J), and there was
an increase in the percentage of AMPA+ cells in 1 week-old cells in
response to mifepristone treatment (Mifepristone F1,27 = 10.900,
p = 0.003; Porsolt F1,27 = 1.433, p = 0.244; Interaction F1,27 =
0.062, p = 0.805: Figure 5 K).
Discussion
There is considerable evidence linking AHN to mood disorders
[50] [51]. Chronic stress is widely considered to be a pathogenic
factor for major depression (MD) and it also provokes a reduction
in AHN [52]. Furthermore, many beneficial strategies to treat of
symptoms of depression selectively enhance AHN [53]. Nonethe-
less, little is known about the mechanisms through which
glucocorticoids interact with developing neurons during AHN.
We quantified the survival of different subpopulations of newborn
hippocampal neurons in response to the Porsolt or forced swim
test, a commonly used a model of acute stress. While chronic stress
is known to induce a general decrease in AHN [9] [54] [25] [55],
there it unclear how acute stress affects this process [56] [57]. In
agreement with our findings, numerous studies have reported that
the proliferation of neuronal precursors in the rodent DG is not
drastically modified by exposure to different acute stresses [58]
[59] [60] [61] [62], although a reduced rate of proliferation in the
hippocampus of shrew monkeys has been described following
acute stress [63].
The exact role of immature newborn neurons remains poorly
understood, although they increasingly appear to be very relevant
in hippocampal functioning [64] [65,66] [67] [68] [69]. The acute
stress induced by the Porsolt test selectively decreased the number
of 1 week-old cells in the DG. Moreover, while this swim test did
not produce a net increase in the total number of apoptotic cells,
the percentage of 1 week-old IdU+ cells undergoing apoptotic
death did augment. This is consistent with several recent studies of
the effects of stress exposure using a stereological approach, in
which no massive apoptotic cell death was reported [61] [32] [70].
Nonetheless, we identified a cell population particularly sensitive
to the effects of acute stress, as well as several populations of more-
mature newborn neurons that are apparently more resistant to
these effects.
Corticosteroids activate two types of receptors, MR and GR, and
while GR activation is involved in acute, stress-induced and
suppressive effects, MR activation is thought to contribute to tonic,
long-term permissive effects [71]. Interestingly, studies in GR
knockout mice have demonstrated significant alterations in
hippocampal neurogenesis [72]. Both receptors are strongly
expressed in limbic structures such as the hippocampus [20] [32]
and our data suggest that increasing corticosteroids exerts an
indirect regulatory effect that is probably mediated by other
components of the stem cell niche [73]. Indeed, many cells whose
survival is affected by acute stress express neither GR nor MR, and
in fact only ,15% of 1 week-old cells express GR+. Furthermore,
the survival of these cells fell by 50% when compared to the
controls. Our data also corroborate the age dependent increase in
the percentage of hippocampal newborn cells expressing both GR
and MR seen elsewhere [33] [74]. Although the percentage of GR+
1 week-old cells we found was relatively low [33], the expression of
GR was previously established in different subpopulations of
immature cells while here we analyzed the expression of GR in a
largely heterogeneous population of 4 to 7 day-old cells, regardless
of the subtype. Methodological differences such as the GR antibody
used, the thresholds established and the different cell populations
analyzed may explain the apparent discrepancies in the proportions
of GR+ cells here and elsewhere [33] [74].
Acute exposure to high levels of GC is known to prevent neural
differentiation in 4 week-old newborn neurons in the DG [75].
Indeed, we found that the swim test-provoked stress that prevents
the maturation of 4 week-old cells, blocking the decrease in the
proportion of DCX+ cells observed in control animals [76] [77],
and reducing other indirect indicators of differentiation, like
migration to the granule layer [78]. The latter observation was
recently linked to the manifestation of depressive-like behaviors
[79]. An alternative explanation for the reduction in the distance
to the hilus in 4 and 6 week-old cells, is that these cells move
toward the hilus in response to stress, or that the loss of cells at 1
week (i.e., those closest to the hilus) results in 4 and 6 week-old cells
appearing closer to the hilus.
Numerous cytokines modify the migration and differentiation of
precursor cells [80] [81]. However, the expression of the pro-
inflammatory cytokines IL-6 or TNF was not altered by the
Porsolt test in the hippocampus, as seen elsewhere [82] [83].
Table 2. Relative hippocampal mRNA expression (fold
increase) in Group E animals.
Control Porsolt
Vehicle Mifepristone Vehicle Mifepristone
IL-6 1.2460.14 1.2260.27 1.2360.24 1.4160.24
TNF 0.9760.08 1.1560.25 0.8060.13 1.2260.32
BDNF 0.9860.05 0.9360.08 1.0560.06 1.1560.08
IGF-I 0.660.1 0.6060.03 0.6960.09 0.5660.04
vGLUT1 1.0960.07 1.0760.08 1.1560.1 1.0260.07
GAD65 1.0860.11 0.9960.07 0.960.04 1.0660.11
GR 1.0660.06 0.9860.07 1.0560.12 0.9860.1
MR 0.8760.04 1.0660.08 0.960.1 0.8260.03
Neither the Porsolt test nor mifepristone administration significantly altered the
mRNA expression of IL-6 (F3,18 = 0.777, p = 0.525), TNF (F3,15 = 1.331, p = 0.31),
BDNF (F3,19 = 1.733, p = 0.201), IGF-I (F3,19 = 1.733, p = 0.201), vGLUT1
(F3,18 = 0.759, p = 0.31), GAD65 (F3,18 = 0.848, p = 0.489), GR (F3,18 = 1.654,
p = 0.222), nor MR (F3,19 = 2.043, p = 0.148). Mouse GAPDH was used as an
endogenous control. The data is presented as the relative increase (Pfaffl
method). IL-6: Interleukin 6. TNF: Tumor necrosis factor. BDNF: Brain-derived
neurotrophic factor. IGF-I: Insulin-like growth factor. vGLUT1: vesicular
glutamate transporter 1. GAD65: Glutamic acid decarboxylase 65. GR:
Glucocorticoid receptor. MR: Mineralocorticoid receptor.
doi:10.1371/journal.pone.0028376.t002
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There is growing evidence that several growth factor systems are
modulated by both the development and treatment of MD. In fact,
both chronic antidepressant treatments and stress regulates BDNF
expression in a complex manner, although the underlying
mechanisms remain poorly understood [84] [85] [86]. We found
no significant changes in hippocampal BDNF expression following
the Porsolt test, in agreement with previous reports [87], nor of
IGF-I. More comprehensive studies will be necessary to determine
if the expression of these growth factors or their receptors can be
detected at different intervals post-stress, or in response to different
stress protocols (e.g., different durations and intensity of stress).
Deregulation of glutamatergic neurotransmission has recently
been implicated in the etiology of several mood disorders [36],
leading to the development of several antidepressant strategies
targeting the glutamatergic system [88] [89]. Transient alterations
in pre-synaptic markers of glutamatergic (vGLUT1) and GA-
Figure 4. Maturation of newborn cells. A Distance between the nucleus of different aged cells and the hilus. This distance increased with cell
age (p,0.001). Exposure to the Porsolt test reduced the distance in 4 (p = 0.001) and 6 week-old (p = 0.002) cells. B–E Representative images of
immunohistochemistry against IdU or CldU (green) and AMPA (blue), in cells counterstained with DAPI (red), showing the relative position of 1 and 6
week-old cells inside the GCL of control animals and those exposed to the Porsolt test. F DCX expression in newborn cells of different ages. The
Porsolt test increased the percentage of 4 week-old cells that were also DCX+(p = 0.022), but had no effect in cells of 1, 2 or 3 weeks of age. G–R
Representative images of double immunohistochemistry for DCX (red) and IdU or CldU (green). DCX+ and DCX- cells are represented by purple and
yellow triangles, respectively. ML: Molecular layer; GCL: Granule cell layer; SGZ: Subgranular zone; H: Hilus. Scale bar = 20 mm.
doi:10.1371/journal.pone.0028376.g004
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BAergic (GAD65) transmission have been reported in models of
chronic mild stress (CMS) [90] [58]. In the present study, the acute
stress of the Porsolt test did not alter the expression of these
markers in the hippocampus 4 hours after the last session,
although later transient modifications cannot be ruled out. One
of the proposed mechanisms mediating glutamate-provoked
neurotoxicity in stress models is the sustained activation of
ionotropic NMDA glutamate receptors [91] [88]. Ionotropic
AMPA receptors play a very different role in these processes, and
possess multiple sites at which ligand binding can fine-tune
receptor activity [92]. AMPA receptors have been functionally
linked to a variety of signal transduction events involving Src-
family kinases, G-proteins, and MAP kinase [43]. Chronic
antidepressant treatment increases the expression of AMPA
receptors at the membrane [42] and requires AMPA activation
to exert antidepressant effects [93] [41]. Moreover, ampakines
exhibit antidepressant-like properties [94] and they are considered
to be potential targets for the treatment of MD [95]. In fact,
enhancing the activity of AMPA receptors regulates dendritogen-
esis [96] and importantly, upregulates AHN [16]. Very immature
and synaptically-silent neurons approximately 1 week old respond
to glutamate by activating both NMDA and AMPA receptors
[98], of which the latter is thought to play an important role in the
proliferation and survival of these cells [16].
The glucocorticoid antagonist family also shows some potential
for the treatment of depression [92] [99] [100] [101]. In
particular, the GR (but not MR) antagonist mifepristone (RU-
486) is currently under study in phase III clinical trials for the
treatment of depression with psychotic features [102]. Short-term
treatment with mifepristone produces antidepressant effects in
animal models of depression [105] and in clinical trials [103]
[104]. Its rapid action is very important given the significant delay
between administration of conventional antidepressants and the
onset of therapeutic effects. Other methods of inhibiting activity in
the HPA axis produce antidepressant effects, such as CRF1
receptor blockade, as well as normalizing AHN levels in animal
models of depression [106] [107].
We found that mifepristone prevents the increase in apoptosis
among 1 week-old cells induced by acute stress. This observation is
consistent with reports that GR blockade can normalize the
reduction in cell survival produced by the elevated GC levels
mediated by chronic stress [38] [39]. In our study, the effects of
mifepristone on cell survival were not associated with short term
effects on animal behavior in the Porsolt test, an interesting
observation given that AHN integrity is essential for different
forms of learning [4] [108]. The absence of an antidepressant
effect in the Porsolt test observed following acute mifepristone
treatment is consistent with the dependence of the antidepressant
effects of GR antisense mRNAs on the exact moment of
administration in animal models of stress [109].
In conjunction with the classically-described effects of GR
antagonism [110] [103], the intrinsic antioxidant properties of
mifepristone are thought to promote neuronal survival [40], as
oxidative stress produced by glucocorticoids appears to underlie
some of their neurotoxic effects [111] [73]. However, the effects of
mifepristone are more potent in environments with high
glucocorticoid levels, as it does not modify proliferation or survival
in control animals [38]. Moreover, the pro-survival effects of
mifepristone appear to be selective for this cell population, as it did
not modify the size of any of the other populations analyzed.
Figure 5. Effects of mifepristone and the Porsolt test on AMPA receptor expression in newborn cells. A AMPA receptor expression in
cells of different ages. AMPA receptor expression increased with age (p,0.001). B–J Images of double immunohistochemistry for the AMPA receptor
(red) and IdU or CldU (green). The majority of 7 week-old cells were AMPA+. K Modulation of AMPA receptor expression by mifepristone. Mifepristone
increased the proportion of AMPA+ cells in 1 week-old newborn cells (p = 0.003). ML: Molecular layer; GCL: Granule cell layer; SGZ: Subgranular zone;
H: Hilus. Scale bar = 50 mm.
doi:10.1371/journal.pone.0028376.g005
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Mifepristone selectively increased the percentage of 1 week-old
IdU+ cells expressing the AMPA receptor. Further studies will be
necessary to determine whether this increase in AMPA expression
contributes to the increase in cell survival in high glucocorticoid
environments. However, we hypothesize that AMPA receptor
expression may exert a neuroprotective effect on this cell
population. Indeed, diverse ampakines have been attributed
neuroprotective properties [97], making them novel targets for
the treatment of depression [95]. The putative pro-survival effect
of increased AMPA receptor expression in cell populations
particularly sensitive to stress suggests a novel mechanism of
action underlying the neuroprotective effects of mifepristone.
Supporting Information
Figure S1 Neither the Porsolt test nor mifepristone modified the
total number of DCX+ cells (Mifepristone F1,28 = 1.236, p = 0.277;
Porsolt F1,28 = 0.070, p = 0.793; Interaction F1,28 = 0.197,
p = 0.661) (A), pH3+ cells (Mifepristone F1,27 = 0.002, p = 0.967;
Porsolt F1,27 = 0.098, p = 0.757; Interaction F1,27 = 0.017, p =
0.899) (B), mature granule cells (Mifepristone F1,29 = 0.003,
p = 0.717; Porsolt F1,29 = 0.378, p = 0.544; Interaction F1,29 =
0.468, p = 0.444) (C), or the volume of the DG (Mifepristone
F1,27 = 0.003, p = 0.090; Porsolt F1,27 = 0.378, p = 0.337; Interac-
tion F1,27 = 0.468, p = 0.459) (D). Likewise, neither the Porsolt test
or mifepristone affected the total number of 7 week-old CldU+
cells (Mifepristone F1,28 = 0.073, p = 0.789; Porsolt F1,28 = 0.052,
p = 0.821; Interaction F1,28 = 0.202, p = 0.657) (E). F: Acute
mifepristone treatment had no effect on the immobility time in
the Porsolt test (F1,23 = 0.742, p = 0.398).
(TIF)
Acknowledgments
The authors wish to thank Carmen Herna´ndez, Bele´n Garcı´a and Jose´ Luis
Rojas for their technical assistance with confocal microscopy. We also
appreciate the assistance of Ana LLorens-Martı´n in revising the manuscript
and Dr Fabio Cafini for critical discussion of the results.
Author Contributions
Conceived and designed the experiments: ML-M. Performed the
experiments: ML-M. Analyzed the data: ML-M. Contributed reagents/
materials/analysis tools: ML-M JLT. Wrote the paper: ML-M JLT.
Acquisition of funding: JLT.
References
1. Gage FH (2000) Mammalian neural stem cells. Science 287: 1433–1438.
2. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, et al.
(1998) Neurogenesis in the adult human hippocampus. Nat Med 4: 1313–1317.
3. Deng W, Aimone JB, Gage FH (2010) New neurons and new memories: how
does adult hippocampal neurogenesis affect learning and memory? Nat Rev
Neurosci 11: 339–350.
4. Garthe A, Behr J, Kempermann G (2009) Adult-generated hippocampal
neurons allow the flexible use of spatially precise learning strategies. PLoS One
4: e5464.
5. Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is
decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsy-
chopharmacology 28: 1562–1571.
6. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. (2003) Requirement
of hippocampal neurogenesis for the behavioral effects of antidepressants.
Science 301: 805–809.
7. Van PH, Kempermann G, Gage FH (1999) Running increases cell
proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci
2: 266–270.
8. Llorens-Martin M, Tejeda GS, Trejo JL (2010) Differential regulation of the
variations induced by environmental richness in adult neurogenesis as a
function of time: a dual birthdating analysis. PLoS One 5: 10.1371/
journal.pone.0012188 [doi].
9. Cameron HA, Gould E (1994) Adult neurogenesis is regulated by adrenal
steroids in the dentate gyrus. Neuroscience 61: 203–209.
10. Sairanen M, Lucas G, Ernfors P, Castren M, Castren E (2005) Brain-derived
neurotrophic factor and antidepressant drugs have different but coordinated
effects on neuronal turnover, proliferation, and survival in the adult dentate
gyrus. J Neurosci 25: 1089–1094.
11. Trejo JL, Llorens-Martin MV, Torres-Aleman I (2008) The effects of exercise
on spatial learning and anxiety-like behavior are mediated by an IGF-I-
dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci
37: 402–411.
12. Trejo JL, Carro E, Torres-Aleman I (2001) Circulating insulin-like growth
factor I mediates exercise-induced increases in the number of new neurons in
the adult hippocampus. J Neurosci 21: 1628–1634.
13. Llorens-Martin M, Torres-Aleman I, Trejo JL (2010) Exercise modulates
insulin-like growth factor 1-dependent and -independent effects on adult
hippocampal neurogenesis and behaviour. Mol Cell Neurosci 44: 109–117.
14. Schanzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, et al. (2004)
Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by
vascular endothelial growth factor. Brain Pathol 14: 237–248.
15. Gould E, Cameron HA, McEwen BS (1994) Blockade of NMDA receptors
increases cell death and birth in the developing rat dentate gyrus. J Comp
Neurol 340: 551–565.
16. Bai F, Bergeron M, Nelson DL (2003) Chronic AMPA receptor potentiator
(LY451646) treatment increases cell proliferation in adult rat hippocampus.
Neuropharmacology 44: 1013–1021.
17. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult
hippocampal neurogenesis. Science 302: 1760–1765.
18. Gould E, Woolley CS, McEwen BS (1991) Adrenal steroids regulate postnatal
development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death.
J Comp Neurol 313: 479–485.
19. Wong EY, Herbert J (2005) Roles of mineralocorticoid and glucocorticoid
receptors in the regulation of progenitor proliferation in the adult hippocam-
pus. Eur J Neurosci 22: 785–792.
20. Joels M (2007) Role of corticosteroid hormones in the dentate gyrus. Prog Brain
Res 163: 355–370.
21. Reagan LP, McEwen BS (1997) Controversies surrounding glucocorticoid-
mediated cell death in the hippocampus. J Chem Neuroanat 13: 149–167.
22. Ahmed T, Frey JU, Korz V (2006) Long-term effects of brief acute stress on
cellular signaling and hippocampal LTP. J Neurosci 26: 3951–3958.
23. Quirarte GL, de lT, I, Casillas M, Serafin N, Prado-Alcala RA, et al. (2009)
Corticosterone infused into the dorsal striatum selectively enhances memory
consolidation of cued water-maze training. Learn Mem 16: 586–589.
24. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, et al. (2009) The
inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for
future research and new drug developments in depression. Metab Brain Dis 24:
27–53.
25. Sterner EY, Kalynchuk LE (2010) Behavioral and neurobiological conse-
quences of prolonged glucocorticoid exposure in rats: relevance to depression.
Prog Neuropsychopharmacol Biol Psychiatry 34: 777–790.
26. McEwen BS (2003) Mood disorders and allostatic load. Biol Psychiatry 54:
200–207.
27. Dhikav V, Anand KS (2007) Glucocorticoids may initiate Alzheimer’s disease:
a potential therapeutic role for mifepristone (RU-486). Med Hypotheses 68:
1088–1092.
28. Luine V, Villegas M, Martinez C, McEwen BS (1994) Stress-dependent
impairments of spatial memory. Role of 5-HT. Ann N Y Acad Sci 746:
403–404.
29. Li WZ, Li WP, Yao YY, Zhang W, Yin YY, et al. (2010) Glucocorticoids
increase impairments in learning and memory due to elevated amyloid
precursor protein expression and neuronal apoptosis in 12-month old mice.
Eur J Pharmacol 628: 108–115.
30. Sousa N, Cerqueira JJ, Almeida OF (2008) Corticosteroid receptors and
neuroplasticity. Brain Res Rev 57: 561–570.
31. Fitzsimons CP, van Hooijdonk LW, Morrow JA, Peeters BW, Hamilton N, et
al. (2009) Antiglucocorticoids, neurogenesis and depression. Mini Rev Med
Chem 9: 249–264.
32. Sousa N, Almeida OF (2002) Corticosteroids: sculptors of the hippocampal
formation. Rev Neurosci 13: 59–84.
33. Garcia A, Steiner B, Kronenberg G, Bick-Sander A, Kempermann G (2004)
Age-dependent expression of glucocorticoid- and mineralocorticoid receptors
on neural precursor cell populations in the adult murine hippocampus. Aging
Cell 3: 363–371.
34. Tata DA, Anderson BJ (2010) The effects of chronic glucocorticoid exposure
on dendritic length, synapse numbers and glial volume in animal models:
implications for hippocampal volume reductions in depression. Physiol Behav
99: 186–193.
35. de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation
to disease. Nat Rev Neurosci 6: 463–475.
36. Zarate CA, Jr., Du J, Quiroz J, Gray NA, Denicoff KD, et al. (2003)
Regulation of cellular plasticity cascades in the pathophysiology and treatment
of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci 1003:
273–291.
Mifepristone Increases AMPAR in Newborn Neurons
PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e28376
37. Lowy MT, Wittenberg L, Yamamoto BK (1995) Effect of acute stress on
hippocampal glutamate levels and spectrin proteolysis in young and aged rats.
J Neurochem 65: 268–274.
38. Oomen CA, Mayer JL, de Kloet ER, Joels M, Lucassen PJ (2007) Brief
treatment with the glucocorticoid receptor antagonist mifepristone normalizes
the reduction in neurogenesis after chronic stress. Eur J Neurosci 26:
3395–3401.
39. Mayer JL, Klumpers L, Maslam S, de Kloet ER, Joels M, et al. (2006) Brief
treatment with the glucocorticoid receptor antagonist mifepristone normalises
the corticosterone-induced reduction of adult hippocampal neurogenesis.
J Neuroendocrinol 18: 629–631.
40. Behl C, Trapp T, Skutella T, Holsboer F (1997) Protection against oxidative
stress-induced neuronal cell death–a novel role for RU486. Eur J Neurosci 9:
912–920.
41. Karasawa J, Shimazaki T, Kawashima N, Chaki S (2005) AMPA receptor
stimulation mediates the antidepressant-like effect of a group II metabotropic
glutamate receptor antagonist. Brain Res 1042: 92–98.
42. Martinez-Turrillas R, Del RJ, Frechilla D (2007) Neuronal proteins involved in
synaptic targeting of AMPA receptors in rat hippocampus by antidepressant
drugs. Biochem Biophys Res Commun 353: 750–755.
43. Suppiramaniam V, Bahr BA, Sinnarajah S, Owens K, Rogers G, et al. (2001)
Member of the Ampakine class of memory enhancers prolongs the single
channel open time of reconstituted AMPA receptors. Synapse 40: 154–158.
44. Llorens-Martin MV, Rueda N, Martinez-Cue C, Torres-Aleman I, Florez J,
et al. (2007) Both increases in immature dentate neuron number and decreases
of immobility time in the forced swim test occurred in parallel after
environmental enrichment of mice. Neuroscience 147: 631–638.
45. Porsolt RD, Le PM, Jalfre M (1977) Depression: a new animal model sensitive
to antidepressant treatments. Nature 266: 730–732.
46. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced
swimming test differentially produced by serotonergic and noradrenergic
antidepressants. Psychopharmacology (Berl) 121: 66–72.
47. Llorens-Martin M, Torres-Aleman I, Trejo JL (2006) Pronounced individual
variation in the response to the stimulatory action of exercise on immature
hippocampal neurons. Hippocampus 16: 480–490.
48. Leuner B, Glasper ER, Gould E (2009) Thymidine analog methods for studies
of adult neurogenesis are not equally sensitive. J Comp Neurol 517: 123–133.
49. Pfaffl MW (2010) The ongoing evolution of qPCR. Methods 50: 215–216.
50. Becker S, Wojtowicz JM (2007) A model of hippocampal neurogenesis in
memory and mood disorders. Trends Cogn Sci 11: 70–76.
51. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of
mood disorders. Neuromolecular Med 5: 11–25.
52. Mirescu C, Gould E (2006) Stress and adult neurogenesis. Hippocampus 16:
233–238.
53. Encinas JM, Vaahtokari A, Enikolopov G (2006) Fluoxetine targets early
progenitor cells in the adult brain. Proc Natl Acad Sci U S A 103: 8233–8238.
54. Tanapat P, Galea LA, Gould E (1998) Stress inhibits the proliferation of
granule cell precursors in the developing dentate gyrus. Int J Dev Neurosci 16:
235–239.
55. Brummelte S, Galea LA (2010) Chronic high corticosterone reduces
neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience
168: 680–690.
56. Dagyte G, Van der Zee EA, Postema F, Luiten PG, Den Boer JA, et al. (2009)
Chronic but not acute foot-shock stress leads to temporary suppression of cell
proliferation in rat hippocampus. Neuroscience 162: 904–913.
57. Heine VM, Maslam S, Zareno J, Joels M, Lucassen PJ (2004) Suppressed
proliferation and apoptotic changes in the rat dentate gyrus after acute and
chronic stress are reversible. Eur J Neurosci 19: 131–144.
58. Autry AE, Grillo CA, Piroli GG, Rothstein JD, McEwen BS, et al. (2006)
Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression
in the rat hippocampus. Neuroendocrinology 83: 371–379.
59. Thomas RM, Hotsenpiller G, Peterson DA (2007) Acute psychosocial stress
reduces cell survival in adult hippocampal neurogenesis without altering
proliferation. J Neurosci 27: 2734–2743.
60. Lee KJ, Kim SJ, Kim SW, Choi SH, Shin YC, et al. (2006) Chronic mild stress
decreases survival, but not proliferation, of new-born cells in adult rat
hippocampus. Exp Mol Med 38: 44–54.
61. Leverenz JB, Wilkinson CW, Wamble M, Corbin S, Grabber JE, et al. (1999)
Effect of chronic high-dose exogenous cortisol on hippocampal neuronal
number in aged nonhuman primates. J Neurosci 19: 2356–2361.
62. Thomas RM, Urban JH, Peterson DA (2006) Acute exposure to predator odor
elicits a robust increase in corticosterone and a decrease in activity without
altering proliferation in the adult rat hippocampus. Exp Neurol 201: 308–315.
63. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E (1997) Neurogenesis in
the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and
NMDA receptor activation. J Neurosci 17: 2492–2498.
64. Wiskott L, Rasch MJ, Kempermann G (2006) A functional hypothesis for adult
hippocampal neurogenesis: avoidance of catastrophic interference in the
dentate gyrus. Hippocampus 16: 329–343.
65. Kee N, Teixeira CM, Wang AH, Frankland PW (2007) Preferential
incorporation of adult-generated granule cells into spatial memory networks
in the dentate gyrus. Nat Neurosci 10: 355–362.
66. Schmidt-Hieber C, Jonas P, Bischofberger J (2004) Enhanced synaptic
plasticity in newly generated granule cells of the adult hippocampus. Nature
429: 184–187.
67. Van PH, Schinder AF, Christie BR, Toni N, Palmer TD, et al. (2002)
Functional neurogenesis in the adult hippocampus. Nature 415: 1030–1034.
68. Wang S, Scott BW, Wojtowicz JM (2000) Heterogenous properties of dentate
granule neurons in the adult rat. J Neurobiol 42: 248–257.
69. Lagace DC, Donovan MH, DeCarolis NA, Farnbauch LA, Malhotra S, et al.
(2010) Adult hippocampal neurogenesis is functionally important for stress-
induced social avoidance. Proc Natl Acad Sci U S A 107: 4436–4441.
70. Czeh B, Lucassen PJ (2007) What causes the hippocampal volume decrease in
depression? Are neurogenesis, glial changes and apoptosis implicated? Eur
Arch Psychiatry Clin Neurosci 257: 250–260.
71. Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids
influence stress responses? Integrating permissive, suppressive, stimulatory, and
preparative actions. Endocr Rev 21: 55–89.
72. Kronenberg G, Kirste I, Inta D, Chourbaji S, Heuser I, et al. (2009) Reduced
hippocampal neurogenesis in the GR(+/-) genetic mouse model of depression.
Eur Arch Psychiatry Clin Neurosci 259: 499–504.
73. Behl C, Lezoualc’h F, Trapp T, Widmann M, Skutella T, et al. (1997)
Glucocorticoids enhance oxidative stress-induced cell death in hippocampal
neurons in vitro. Endocrinology 138: 101–106.
74. Cameron HA, Woolley CS, Gould E (1993) Adrenal steroid receptor
immunoreactivity in cells born in the adult rat dentate gyrus. Brain Res 611:
342–346.
75. Wong EY, Herbert J (2006) Raised circulating corticosterone inhibits neuronal
differentiation of progenitor cells in the adult hippocampus. Neuroscience 137:
83–92.
76. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, et al.
(2003) Transient expression of doublecortin during adult neurogenesis. J Comp
Neurol 467: 1–10.
77. Kempermann G, Jessberger S, Steiner B, Kronenberg G (2004) Milestones of
neuronal development in the adult hippocampus. Trends Neurosci 27:
447–452.
78. Kempermann G, Gast D, Kronenberg G, Yamaguchi M, Gage FH (2003)
Early determination and long-term persistence of adult-generated new neurons
in the hippocampus of mice. Development 130: 391–399.
79. Lussier AL, Caruncho HJ, Kalynchuk LE (2009) Repeated exposure to
corticosterone, but not restraint, decreases the number of reelin-positive cells in
the adult rat hippocampus. Neurosci Lett 460: 170–174.
80. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC (2009) Inflammation
mediates varying effects in neurogenesis: relevance to the pathogenesis of brain
injury and neurodegenerative disorders. J Neurochem 108: 1343–1359.
81. Das S, Basu A (2008) Inflammation: a new candidate in modulating adult
neurogenesis. J Neurosci Res 86: 1199–1208.
82. Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, et al. (2010)
Regulation of adult neurogenesis by stress, sleep disruption, exercise and
inflammation: Implications for depression and antidepressant action. Eur
Neuropsychopharmacol 20: 1–17.
83. Frank MG, Miguel ZD, Watkins LR, Maier SF (2010) Prior exposure to
glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory
responses to E. coli lipopolysaccharide. Brain Behav Immun 24: 19–30.
84. Castren E, Voikar V, Rantamaki T (2007) Role of neurotrophic factors in
depression. Curr Opin Pharmacol 7: 18–21.
85. Duman RS (2005) Neurotrophic factors and regulation of mood: role of
exercise, diet and metabolism. Neurobiol Aging 26 Suppl 1: 88–93.
86. Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003) Differential regulation of
brain derived neurotrophic factor transcripts by antidepressant treatments in
the adult rat brain. Neuropharmacology 45: 553–563.
87. Nair A, Vadodaria KC, Banerjee SB, Benekareddy M, Dias BG, et al. (2007)
Stressor-specific regulation of distinct brain-derived neurotrophic factor
transcripts and cyclic AMP response element-binding protein expression in
the postnatal and adult rat hippocampus. Neuropsychopharmacology 32:
1504–1519.
88. Papp M, Moryl E (1993) New evidence for the antidepressant activity of MK-
801, a non-competitive antagonist of NMDA receptors. Pol J Pharmacol 45:
549–553.
89. Sapolsky RM (2000) The possibility of neurotoxicity in the hippocampus in
major depression: a primer on neuron death. Biol Psychiatry 48: 755–765.
90. Elizalde N, Garcia-Garcia AL, Totterdell S, Gendive N, Venzala E, et al.
(2010) Sustained stress-induced changes in mice as a model for chronic
depression. Psychopharmacology (Berl) 210: 393–406.
91. Boyer PA, Skolnick P, Fossom LH (1998) Chronic administration of
imipramine and citalopram alters the expression of NMDA receptor subunit
mRNAs in mouse brain. A quantitative in situ hybridization study. J Mol
Neurosci 10: 219–233.
92. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, et al. (2003) Enhancing
neuronal plasticity and cellular resilience to develop novel, improved
therapeutics for difficult-to-treat depression. Biol Psychiatry 53: 707–742.
93. Maeng S, Zarate CA, Jr., Du J, Schloesser RJ, McCammon J, et al. (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine: role of
alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol
Psychiatry 63: 349–352.
Mifepristone Increases AMPAR in Newborn Neurons
PLoS ONE | www.plosone.org 11 November 2011 | Volume 6 | Issue 11 | e28376
94. Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, et al. (2001)
Antidepressant-like actions of an AMPA receptor potentiator (LY392098).
Neuropharmacology 40: 1028–1033.
95. Zarate CA, Jr., Manji HK (2008) The role of AMPA receptor modulation in
the treatment of neuropsychiatric diseases. Exp Neurol 211: 7–10.
96. Voss OP, Milne S, Sharkey J, O’Neill MJ, McCulloch J (2007) Molecular
mechanisms of neurite growth with AMPA receptor potentiation. Neurophar-
macology 52: 590–597.
97. Su XW, Li XY, Banasr M, Koo JW, Shahid M, et al. (2009) Chronic treatment
with AMPA receptor potentiator Org 26576 increases neuronal cell
proliferation and survival in adult rodent hippocampus. Psychopharmacology
(Berl) 206: 215–222.
98. Ambrogini P, Minelli A, Lattanzi D, Ciuffoli S, Fanelli M, et al. (2006)
Synaptically-silent immature neurons show gaba and glutamate receptor-
mediated currents in adult rat dentate gyrus. Arch Ital Biol 144: 115–126.
99. DeBattista C, Belanoff J, Glass S, Khan A, Horne RL, et al. (2006)
Mifepristone versus placebo in the treatment of psychosis in patients with
psychotic major depression. Biol Psychiatry 60: 1343–1349.
100. Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (2001) Rapid
reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 21:
516–521.
101. Murphy BE, Filipini D, Ghadirian AM (1993) Possible use of glucocorticoid
receptor antagonists in the treatment of major depression: preliminary results
using RU 486. J Psychiatry Neurosci 18: 209–213.
102. Nihalani ND, Schwartz TL (2007) Mifepristone, a glucocorticoid antagonist for
the potential treatment of psychotic major depression. Curr Opin Investig
Drugs 8: 563–569.
103. Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF (2006) Clinical
and biological effects of mifepristone treatment for psychotic depression.
Neuropsychopharmacology 31: 628–636.
104. Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, et al. (2002)
An open label trial of C-1073 (mifepristone) for psychotic major depression.
Biol Psychiatry 52: 386–392.
105. Veldhuis HD, De Korte CC, de Kloet ER (1985) Glucocorticoids facilitate the
retention of acquired immobility during forced swimming. Eur J Pharmacol
115: 211–217.
106. Overstreet DH, Griebel G (2004) Antidepressant-like effects of CRF1 receptor
antagonist SSR125543 in an animal model of depression. Eur J Pharmacol
497: 49–53.
107. Alonso R, Griebel G, Pavone G, Stemmelin J, le FG, et al. (2004) Blockade of
CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis
in a mouse model of depression. Mol Psychiatry 9: 278–86, 224.
108. Dupret D, Fabre A, Dobrossy MD, Panatier A, Rodriguez JJ, et al. (2007)
Spatial learning depends on both the addition and removal of new
hippocampal neurons. PLoS Biol 5: e214.
109. Korte SM, de Kloet ER, Buwalda B, Bouman SD, Bohus B (1996) Antisense to
the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in
forced swim test. Eur J Pharmacol 301: 19–25.
110. Peeters BW, Ruigt GS, Craighead M, Kitchener P (2008) Differential effects of
the new glucocorticoid receptor antagonist ORG 34517 and RU486
(mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20
cell line. Ann N Y Acad Sci 1148: 536–541.
111. You JM, Yun SJ, Nam KN, Kang C, Won R, et al. (2009) Mechanism of
glucocorticoid-induced oxidative stress in rat hippocampal slice cultures.
Can J Physiol Pharmacol 87: 440–447.
Mifepristone Increases AMPAR in Newborn Neurons
PLoS ONE | www.plosone.org 12 November 2011 | Volume 6 | Issue 11 | e28376
